Sökning: onr:"swepub:oai:DiVA.org:liu-35971" >
Expression of COX-2...
-
Gunnarsson, Cecilia,1970-Linköpings universitet,Onkologi,Hälsouniversitetet
(författare)
Expression of COX-2 and steroid converting enzymes in breast cancer
- Artikel/kapitelEngelska2006
Förlag, utgivningsår, omfång ...
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:liu-35971
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-35971URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:112175381URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
COX-2 is upregulated in many breast tumors, and one of the products of COX-2 is PGE2 that is suggested to upregulate aromatase through cAMP signaling in breast cancer. Although aromatase can increase the estrogen levels in tumors, 17β-hydroxysteroid dehydrogenase (17HSD) activity is finally needed for the estrone/estradiol regulation. The aim of this study was to investigate if the protein expression of enzymes involved in estrogen synthesis shows covariation with the expression of COX-2. We also wanted to correlate these results with prognosis. We analyzed the expression of COX-2, aromatase, 17HSD1 and 17HSD2 with immunohistochemistry using tissue microarrays composed of 356 primary breast tumors. In the present study COX-2 was correlated to aromatase (P<0.00001), 17HSD1 (P=0.0073), and 17HSD2 (P<0.00001). Patients with ER positive tumors expressing low amounts of 17HSD2 had decreased breast cancer survival (P=0.013). Elevated expression of COX-2 and aromatase was more frequent among larger tumors (P=0.017 and P=0.013). COX-2 expression correlates with the levels of the examined steroid converting enzymes and may contribute to increased estrogen levels in the tumor. In breast cancer cells, the regulatory function of 17HSD2 could be lost, and in the present study patients with low or non-detectable levels of 17HSD2 had worse prognosis than had breast cancer patients with higher levels of the enzyme.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Jansson, Agneta,1973-Linköpings universitet,Onkologi,Hälsouniversitetet(Swepub:liu)agnja94
(författare)
-
Holmlund, BirgittaLinköpings universitet,Onkologi,Hälsouniversitetet(Swepub:liu)birho30
(författare)
-
Ferraud, LilianneLinköpings universitet,Onkologi,Hälsouniversitetet
(författare)
-
Nordenskjöld, Bo,1940-Linköpings universitet,Onkologi,Hälsouniversitetet(Swepub:liu)bono64
(författare)
-
Rutqvist, Lars ErikClinic of Oncology, Karolinska University Hospital, Stockholm, Sweden
(författare)
-
Skoog, LambertKarolinska Institutet
(författare)
-
Stål, Olle,1952-Linköpings universitet,Onkologi,Hälsouniversitetet(Swepub:liu)ollst87
(författare)
-
Linköpings universitetOnkologi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Oncology Reports16:2, s. 219-2241021-335X1791-2431
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Gunnarsson, Ceci ...
-
Jansson, Agneta, ...
-
Holmlund, Birgit ...
-
Ferraud, Liliann ...
-
Nordenskjöld, Bo ...
-
Rutqvist, Lars E ...
-
visa fler...
-
Skoog, Lambert
-
Stål, Olle, 1952 ...
-
visa färre...
- Artiklar i publikationen
-
Oncology Reports
- Av lärosätet
-
Linköpings universitet
-
Karolinska Institutet